Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Bayer AG’s Contraceptive Flexyess Gets EU Approval-Reuters


Tuesday, 9 Oct 2012 02:33am EDT 

Reuters reported that Bayer AG’s contraceptive Flexyess has received the European Union (EU) approval. The Company announced that the health authorities of the EU member states will grant national approvals for Flexyess in the coming weeks. 

Latest Key Developments in Pharmaceuticals

Company Quote

101.15
0.35 +0.35%
11 Jul 2014